The invention provides a Salivary Biomarker Panel for Therapeutic Monitoring and Relapse Prediction in Head and Neck Cancers, comprising a synergistic combination of miR-1307-5p, CD44v6, KRT4, and PD-L1 quantified from salivary extracellular vesicles. Biomarker expression values are processed through a structured wo...